Cargando…
Perspectives on recent reviews of aspartame cancer epidemiology
Aspartame is a dipeptide non-sugar sweetener that was first marketed in the US in carbonated beverages in 1983, before gaining prominence globally. The Joint Food and Agriculture Organization of the United Nations (FAO)/World Health Organization (WHO) Expert Committee on Food Additives (JECFA) and t...
Autores principales: | Goodman, Julie E., Boon, Denali N., Jack, Maia M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10446002/ https://www.ncbi.nlm.nih.gov/pubmed/37637718 http://dx.doi.org/10.1016/j.gloepi.2023.100117 |
Ejemplares similares
-
The role of study quality in aspartame and cancer epidemiology study reviews
por: Goodman, Julie E., et al.
Publicado: (2023) -
Aspartame and cancer – new evidence for causation
por: Landrigan, Philip J., et al.
Publicado: (2021) -
Aspartame Not Linked to Cancer
por: Abegaz, Eyassu G.
Publicado: (2007) -
Considerations towards the better integration of epidemiology into quantitative risk assessment
por: Déglin, Sandrine E., et al.
Publicado: (2022) -
Why did EFSA not reduce its ADI for aspartame or recommend its use should no longer be permitted?
por: Millstone, Erik Paul, et al.
Publicado: (2020)